Delivery Order SPE2DB22D3011-SPE2DB25FQ2MP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,928.40 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price, non-set-aside contract is classified as a child award, indicating it derives from a larger contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,653.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-count units). The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by August 5, 2025, and will be performed at the awardee's Conshohocken, Pennsylvania location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-count units) with a ceiling value of $5,716.32. This firm fixed-price delivery order is set to be completed by August 12, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $10,266.71 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray. This contract, which was competitively awarded with no set-aside designation, has a firm fixed price structure and an ultimate completion date of August 18, 2025. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- On July 17, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,816.88 to AmerisourceBergen Drug Corp for the supply of Naloxone 4mg nasal spray (2-pack units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 13, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among...
- The Defense Logistics Agency awarded a delivery order valued at $1,124.16 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed price contract was awarded competitively with no set-aside designation and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray on July 24, 2025, with a ceiling value of $1,583.26 and an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger indefinite delivery vehicle with DLA. This delivery order falls...
- The Defense Logistics Agency awarded a $3,984.02 delivery order to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on August 7, 2025, with completion targeted for August 8, 2025. This is a firm fixed price, non-set-aside contract utilizing a competitive award process. The contractor will perform this delivery order from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,470.53 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a $11,472.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-count units). This is a non-set-aside contract with an ultimate completion date of August 12, 2025, and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2MPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Naloxone HCL 4 mg nasal spray in a quantity of 2 units. This contract is valued at $1,135.68 with a firm fixed price structure and an ultimate completion date of September 2, 2025. The award was competitively procured with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a direct fulfillment of federal medical supply requirements through the Defense Logistics Agency's pharmaceutical procurement operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The parent IDC enables the company to serve customers including the Defense Health Agency and U.S. Coast Guard through a flexible contract vehicle that supports global pharmaceutical supply needs across multiple therapeutic domains, including emergency medical supplies such as naloxone used for opioid overdose response.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/29/25 |